Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Maria Buti, Juan Carlos Ruiz-Cobo, Rafael Esteban, Mar Riveiro-Barciela

Clin Mol Hepatol. 2025;31(Suppl):S196-S204. Published online November 11, 2024

DOI: https://doi.org/10.3350/cmh.2024.0758

View: 1778 Download: 142 Web of Science: 2 Crossref: 2

Simone Incicco, Salvatore Piano

Clin Mol Hepatol. 2024;30(4):695-697. Published online June 3, 2024

DOI: https://doi.org/10.3350/cmh.2024.0409

View: 1827 Download: 34 Web of Science: 1 Crossref: 1

Marta Tonon, Salvatore Piano

Clin Mol Hepatol. 2022;28(2):273-275. Published online February 14, 2022

DOI: https://doi.org/10.3350/cmh.2022.0036

View: 7797 Download: 248 Web of Science: 3 Crossref: 4

1 |

Viewed By 11442	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 7184	MAFLD: How is it different from NAFLD?
Viewed By 5478	Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment
Viewed By 5134	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 4579	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma

Cited By 349	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 328	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 219	MAFLD: How is it different from NAFLD?
Cited By 113	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 110	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Search